Literature DB >> 30468767

Regulation of the stability and activity of CDC25A and CDC25B by protein phosphatase PP2A and 14-3-3 binding.

Yuri Kohama1, Megumi Saito1, Mizue Yada1, Hiroshi Sakurai2.   

Abstract

Cyclin-dependent kinase (CDK)-activating phosphatases, CDC25A and CDC25B, are labile proteins, and their levels vary in a cell cycle-dependent manner. Immediate-early response IER5 protein negatively regulates the cellular CDC25B levels, and stress-induced IER5 expression potentiates G2/M arrest. IER5 binds to protein phosphatase PP2A and regulates the PP2A substrate specificity. We show that IER5 binds to CDC25B and assists PP2A to convert CDC25B to hypophosphorylated forms. Hypophosphorylation at Ser323 results in the dissociation of CDC25B from 14-3-3 phospho-binding proteins. In IER5 expressing cells, CDC25B dissociated from 14-3-3 is unstable but slightly activated, because 14-3-3 inhibits CDC25B polyubiquitination and CDC25B binding to CDK1. The 14-3-3 binding to CDC25A also impedes CDC25A degradation and CDC25A-CDK2 interaction. We propose that 14-3-3 is an important regulator of CDC25A and CDC25B and that PP2A/IER5 controls the stability and activity of CDC25B through regulating the interaction of CDC25B and 14-3-3.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14‐3-3; CDC25B; Dephosphorylation; IER5; PP2A; Protein degradation

Mesh:

Substances:

Year:  2018        PMID: 30468767     DOI: 10.1016/j.cellsig.2018.11.017

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.

Authors:  Qiankun Luo; Yanfeng Pan; Qiang Fu; Xu Zhang; Shuai Zhou; Pengfei Yu; Huiyuan Tian; Pan Liu; Song Chen; Hongwei Zhang; Tao Qin
Journal:  Cell Biol Toxicol       Date:  2022-02-10       Impact factor: 6.691

2.  Cdc25B is transcriptionally inhibited by IER5 through the NF-YB transcription factor in irradiation-treated HeLa cells.

Authors:  Lixin Ding; Xianzhe Zhao; Qiang Xiong; Xiaoyan Jiang; Xiaodan Liu; Kuke Ding; Pingkun Zhou
Journal:  Toxicol Res (Camb)       Date:  2021-07-29       Impact factor: 2.680

3.  Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma.

Authors:  Thomas R Holmes; Jenan Al Matouq; Matti Holmes; Natasha Sioda; Justin C Rudd; Celia Bloom; Lauren Nicola; Nicholas Y Palermo; Justin G Madson; Sándor Lovas; Laura A Hansen
Journal:  Carcinogenesis       Date:  2021-02-25       Impact factor: 4.944

Review 4.  The role of 14-3-3 proteins in cell signalling pathways and virus infection.

Authors:  Jiaqi Liu; Shengliang Cao; Guofei Ding; Bin Wang; Yingchao Li; Yuzhong Zhao; Qingyuan Shao; Jian Feng; Sidang Liu; Liting Qin; Yihong Xiao
Journal:  J Cell Mol Med       Date:  2021-04-01       Impact factor: 5.310

5.  Dynamic Chromatin States Coupling with Key Transcription Factors in Colitis-Associated Colorectal Cancer.

Authors:  Lin Chen; Zhihui Luo; Chen Zhao; Qinglan Li; Yingjie Geng; Yong Xiao; Ming-Kai Chen; Lianyun Li; Zhen-Xia Chen; Min Wu
Journal:  Adv Sci (Weinh)       Date:  2022-06-16       Impact factor: 17.521

6.  Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer.

Authors:  Thomas R Holmes; Jenan Al-Matouq; Matti Holmes; Lauren Nicola; Justin C Rudd; Sándor Lovas; Laura A Hansen
Journal:  Oncotarget       Date:  2020-09-01

7.  Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells.

Authors:  Siriphorn Chimplee; Sittiruk Roytrakul; Suchada Sukrong; Theera Srisawat; Potchanapond Graidist; Kanyanatt Kanokwiroon
Journal:  Molecules       Date:  2022-01-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.